1. |
Amadeu T, Braune A, Mandarim-de-Lacerda C, et al. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract 2003; 199: 469-73. doi:10.1078/0344-0338-00447.
|
2. |
Ueda K, Yasuda Y, Furuya E, et al.Inadequate blood supply persists in keloids. Scand J Plast Reconstr Surg Hand Surg 2004; 38: 267-71. doi:10.1080/02844310410029552.
|
3. |
Touchi R, Ueda K, Kurokawa N, et al.Central regions of keloids are severely ischaemic. J Plast Reconstr Aesthet Surg 2016; 69: e35-41. doi:10.1016/j.bjps.2015. 11.006.
|
4. |
Bux S, Madaree A.Keloids show regional distribution of proliferative and degenerate connective tissue elements. Cells Tissues Organs 2010; 191: 213-34. doi:10.1159/ 000231899.
|
5. |
Gauglitz GG, Korting HC, Pavicic T, et al.Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17: 113-25. doi:10.2119/molmed.2009.00153.
|
6. |
Yoo MG and Kim IH. Keloids and hypertrophic scars: characteristic vascular structures visualized by using dermoscopy. Ann Dermatol 2014; 26: 603-9. doi:10.5021/ ad.2014.26.5.603.
|
7. |
Boutin AT, Weidemann A, Fu ZX, et al.Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008; 133: 223-34. doi:10.1016/j.cell.2008.02.038.
|
8. |
Jumper N, Paus R, Bayat A.Functional histopathology of keloid disease. Histol Histopathol 2015; 30: 1033-57. doi:10.14670/HH-11-624.
|
9. |
Lametschwandtner A, Staindl O. Angioarchitecture of keloids. A scanning electron microscopy study of a corrosion specimen. HNO 1990; 38: 202-7. German.
|
10. |
Wolfram D, Tzankov A, Pulzl P, et al. Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009; 35: 171-81. doi:10.1111/j.1524-4725.2008.34406.x.
|
11. |
Ghajar CM, Chen X, Harris JW, et al.The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 2008; 94: 1930-41. doi:10.1529/biophysj.107.120774.
|
12. |
Ring HC, Mogensen M, Hussain AA, et al.Imaging of collagen deposition disorders using optical coherence tomography. J Eur Acad Dermatol Venereol 2015; 29: 890-8. doi:10.1111/jdv.12708.
|
13. |
Kurokawa N, Ueda K, Tsuji M.Study of microvascular structure in keloid and hypertrophic scars: density of microvessels and the efficacy of three-dimensional vascular imaging. J Plast Surg Hand Surg 2010; 44: 272-7. doi:10.3109/2000656X.2010.532923.
|
14. |
Liu J, Xu L, Hu D, et al. Advances in the research of laser Doppler perfusion imaging in burn wounds. Zhonghua Shao Shang Za Zhi, 2014, 30: 175-8. Chinese.
|
15. |
Liu Q, Wang X, Jia Y, et al.Increased blood flow in keloids and adjacent skin revealed by laser speckle contrast imaging. Lasers Surg Med 2016; 48: 360-4. doi:10.1002/ lsm.22470.
|
16. |
Hop MJ, Hiddingh J, Stekelenburg C, et al.Cost- effectiveness of laser Doppler imaging in burn care in the Netherlands. BMC Surg 2013; 13: 2. doi:10.1186/1471- 2482-13-2.
|
17. |
Lenasi H.Skin microvascular reactivity in patients with hypothyroidism. Clin Hemorheol Microcirc 2016. doi:10. 3233/CH-162062.
|
18. |
Timar-Banu O, Beauregard H, Tousignant J, et al.Development of noninvasive and quantitative methodologies for the assessment of chronic ulcers and scars in humans. Wound Repair Regen 2001; 9: 123-32.
|
19. |
Ehrlich HP and Kelley SF. Hypertrophic scar: an interruption in the remodeling of repair-a laser Doppler blood flow study. Plast Reconstr Surg 1992; 90: 993-8.
|
20. |
Zhang Z, Kang C, Chen B, et al. The effects of conditioned medium from keloid fibroblasts under hypoxia on angiogenesis. Zhonghua Zheng Xing Wai Ke Za Zhi 2014; 30: 283-8. Chinese. doi:10.3760/cma.j.issn.1009-4598.2014.04.012.
|
21. |
Sloan DF, Brown RD, Wells CH, et al.Tissue gases in human hypertrophic burn scars. Plast Reconstr Surg 1978; 61: 431-6.
|
22. |
Zheng J, Song F, Lu SL, et al.Dynamic hypoxia in scar tissue during human hypertrophic scar progression. Dermatol Surg 2014; 40: 511-8. doi:10.1111/dsu.12474.
|
23. |
Vincent AS, Phan TT, Mukhopadhyay A, et al.Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol 2008; 128: 702-9. doi:10.1038 / sj.jid. 5701107.
|
24. |
Ueda K, Furuya E, Yasuda Y,et al.Keloids have continuous high metabolic activity. Plast Reconstr Surg 1999; 104: 694-8.
|
25. |
Deschene K, Celeste C, Boerboom D, et al.Hypoxia regulates the expression of extracellular matrix associated proteins in equine dermal fibroblasts via HIF1. J Dermatol Sci 2012; 65: 12-8. doi:10.1016/j.jdermsci.2011.09.006.
|
26. |
Zhang Q, Wu Y, Ann DK, et al.Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003; 121: 1005-12. doi:10.1046/j.1523-1747.2003.12564.x.
|
27. |
Nalwoga H, Ahmed L, Arnes JB, et al.Strong Expression of Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer. PLoS One 2016; 11: e0146823. doi:10.1371/journal.pone.0146823.
|
28. |
van der Veer WM, Niessen FB, et al. Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 2011; 19: 292-301. doi:10.1111/j.1524-475X.2011.00692.x.
|
29. |
Gira AK, Brown LF, Washington CV, et al.Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 2004; 50: 850-3. doi:10.1016/j.jaad.2003.11.061.
|
30. |
Steinbrech DS, Mehrara BJ, Chau D, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 1999; 42: 514-9; discussion 519-20.
|
31. |
Mogili NS, Krishnaswamy VR, Jayaraman M, et al.Altered angiogenic balance in keloids: a key to therapeutic intervention. Transl Res 2012; 159: 182-9. doi:10.1016/j. trsl.2011.10.002.
|
32. |
Heldin CH, Moustakas A.Signaling Receptors for TGF-beta Family Members. Cold Spring Harb Perspect Biol 2016; 8. doi:10.1101/cshperspect.a022053.
|
33. |
Wang XB, Wang W, Zhu XC, et al.The potential of asiaticoside for TGF-beta1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension. Life Sci 2015; 137: 56-64. doi:0.1016 /j.lfs.2015.07.016.
|
34. |
Wu D, Kuang RX, Wang Z, et al. Effects of 6-O-carboxymethyl- chitosan on the expression of TGF-β 1 in human hypertrophic scar fibroblasts. Zhong Guo Mei Rong Yi Xue 2011; (02): 240-3. Chinese. doi:10.15909/j.cnki.cn61-1347/r.2011.02.029.
|
35. |
Abdou AG, Maraee AH, Al-Bara AM, et al.Immunohistochemical expression of TGF- beta1 in keloids and hypertrophic scars. Am J Dermatopathol, 2011; 33: 84-91. doi:10.1097/DAD.0b013e3181d0c3ad.
|
36. |
Sanchez-Elsner T, Botella LM, Velasco B, et al.Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 276: 38527-35. doi:10.1074/jbc.M104536200.
|
37. |
Fujiwara M, Muragaki Y, Ooshima A.Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005; 297: 161-9. doi:10.1007/s00403-005-0596-2.
|
38. |
Wang XQ, Liu YK, Qing C, et al.Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. Microvasc Res 2009; 77: 204-11. doi:10.1016/j.mvr. 2008.08.007.
|
39. |
Ichioka S, Ando T, Shibata M, et al.Oxygen consumption of keloids and hypertrophic scars. Ann Plast Surg 2008; 60: 194-7. doi:10.1097/SAP.0b013e318053ec1d.
|
40. |
Kischer CW.The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992; 24: 281-96.
|
41. |
Lynam EC, Xie Y, Dawson R, et al.Severe hypoxia and malnutrition collectively contribute to scar fibroblast inhibition and cell apoptosis. Wound Repair Regen 2015; 23: 664-71. doi:10.1111/wrr.12343.
|